Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer

Korábbi kezelés

• Multi-organ resection during the esophagectomy.
• Participation in any other clinical trial and use of any drug or experimental device, currently or in the 4 weeks prior to inclusion in the study.

Más betegség

• Blood clotting disorder.
• Bleeding esophageal varices.
• Patients with known sensitivities or allergies to its components

Egyéb

• Patients undergoing transhiatal esophagectomy without reconstruction, open Ivor Lewis esophagectomy or other esophageal resections different to ttMILE.
• Emergent-urgent esophagectomy.
• Coloplasty or small bowel plasty.
• Necrotic tissue/gangrene.
• Sponge placement required directly on major vessels.
• Women who are pregnant, suspected of being pregnant or breastfeeding.

• Age ≥ 18 years
• Scheduled for total minimally invasive (laparoscopic or robotic and thoracoscopic) transthoracic Ivor Lewis esophagectomy (ttMILE) due to esophageal cancer and subsequent eso-SPONGE application to prevent anastomotic leakage
• Patients able to read and understand the Patient Information Sheet and sign, if accepted, the Informed Consent Form
• Patients able, at the discretion of the investigator, to comply with the requirements of the study and without impediments to follow the instructions and assessments throughout the study.